Alopecia Treatment Market Synopsis:
Alopecia Treatment Market Size Was Valued at USD 8.60 Billion in 2023, and is Projected to Reach USD 20.78 Billion by 2032, Growing at a CAGR of 10.30% From 2024-2032.
Alopecia Treatment Market consists of products and services used for treatment of hair loss conditions such as androgenic alopecia, alopecia areata and other types of hair thinning. The above treatment encompasses drugs, hair transplantation surgery, non-surgery therapies including PRP therapy, and laser therapy. The market is fueled by the rising need for a remedy to different kinds of baldness with more emphasis put on the health and beauty of hair regrowth.
- One of the leading factors contributing to a growth of the Alopecia Treatment Market is the growing rate of hair loss among people. Other factors like people living longer, having incorrect genes, and increased stress levels make many people go for solutions. Two major factors are making and enhancing the aesthetic concern and the feeling of the availability of the treatments which are also increasing demand for the market.
- Also, technologies range from PRP therapy and minimally invasive hair transplantation are improving the efficiency of these solutions. The growth of the number of healthcare centres and clinics that offer consumable hair restoration treatments is also giving the consumers more avenues to seek professional service, hence the industry growth is steadily encouraged.
Alopecia Treatment Market Trend Analysis:
Indications of an increased inclination towards noninvasive procedures
- One trending factor in the Alopecia Treatment Market is the indications of an increased inclination towards noninvasive procedures such as the Platelet Rich Plasma (PRP) therapy and laser treatment because more patients prefer treatments that have shorter recovery periods and fewer side effects. People are going for these treatments as an option to the normal skin transplants which if required a longer recovery process and are also costly.
- One more trend the usage of which increases from year to year is the personalized treatment provided for hair loss. More and more specific remedies such as individualized dosing plans and treatment strategies are being reported. This trend can be attributed to the fact that the causes of various forms of alopecia are becoming clearer hence different treatment plans are now being tailored to suit every unique client.
The demand for non-surgical and minimally invasive procedures rising
- The demand for non-surgical and minimally invasive procedures is rising in the Alopecia Treatment Market and present huge development opportunities. As consumers look for better solutions, there is a chance to increase the size of the market with new technologies and products that will give good result without complicated operations. There were also opportunities to create new laser therapies, topical treatments and options involving platelet-rich plasma PRP to fulfil this need.
- Asia Pacific and Latin America regions hold a lot of potential for additional growth offerings. An increase in consumers’ disposable income and the growth of awareness of alopecia treatments should provide further growth to these services in regions where hair loss is becoming more evident. Continued development of the healthcare and related facilities and lower priced treatments may also help in increased market development in these geographic locations.
Alopecia Treatment Market Segment Analysis:
Alopecia Treatment Market is Segmented on the basis of Treatment Type, Type of Alopecia, End-User, and Region
Treatment Type, Medications segment is expected to dominate the market during the forecast period
- These products come in the following categories; the medication therapy, hair transplantation, the newly developed Platelet-Rich Plasma (PRP) therapy, laser therapy and those treated as innovational in the Alopecia Treatment Market. The two drugs that have been proved to be useful in the treatment of androgenic alopecia are minoxidil and finasteride; hair transplantation entails making surgical operations on the areas that are bald. PRP treatment entails taking the patients’ blood then spin it and the plasma is then injected in the scalp to encourage hair growth. Low level laser therapy or LLLT is used in therapies for hair regrowth and prevention of hair loss. Other treatment involves some natural and other alternative treatment that are quickly emerging.
Type of Alopecia, Androgenic Alopecia segment expected to held the largest share
- The Alopecia Treatment Market deals with different forms of alopecia, and androgenic alopecia considered as the most prevalent type of hair loss, a major cause of which is genetic factors. Another autoimmune disease is alopecia areata, which also results in hair loss mostly on the head in patches. Telogen effluvium is a form of hair loss that develops after months of abruption or stress resulting in hormonal changes. Cicatricial alopecia can be defined as a collective term used in description of a given category of hair loss disorders that exhibit a characteristic feature where the said hair follicles are irreversibly damaged and scarred. The market also includes other types of hair loss conditions, namely those associated with special diseases or environmental factors, diet etc.
Alopecia Treatment Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- The alopecia treatment market is led by North America because there is an elevated rate of hair loss disorders, the growing topples of the geriatric population, and an increasing purchasing power among the population in the region. The region has well developed health care systems that provides equal access to the best treatment procedures and equipments. The need for reconstructive as well as aesthetic hair surgeries tends to increase, which goes a long way in boosting market development in North America.
- Furthermore, market dominance has been posteriorities by the existence of premier key stakeholders, prevalence of research and development activities, and encouraging use of new treatments in North America. The region is anticipated to sustain market leadership position in the coming years given the consumer base strength and healthcare friendly environment.
Active Key Players in the Alopecia Treatment Market:
- Allergan (Ireland)
- Bausch Health (Canada)
- Bosley (USA)
- Hair Club (USA)
- Hugel (South Korea)
- Merck & Co. (USA)
- Reviva Labs (USA)
- Rogaine (USA)
- Stemcell Technologies (Canada)
- Tucel (USA)
- Other key Players, and other Active Players
Key Industry Development in the Alopecia Treatment Market:
- In December 2023, Sun Pharmaceutical Industries Ltd. entered into a strategic collaboration with Aclaris. Sun Pharma will get exclusive rights for the use of deuruxolitinib JAK inhibitor or other isotopic forms of ruxolitinib used to treat alopecia areata and androgenetic alopecia
Alopecia Treatment Market Scope:
|
Global Alopecia Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 8.60 Billion |
|
Forecast Period 2024-32 CAGR: |
10.30% |
Market Size in 2032: |
USD 20.78 Billion |
|
Segments Covered: |
Treatment Type |
|
|
|
Type of Alopecia |
|
||
|
End-User |
Home Care |
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Alopecia Treatment Market by Treatment Type (2018-2032)
4.1 Alopecia Treatment Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Medications
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Hair Transplantation
4.5 Platelet-Rich Plasma(PRP) Therapy
4.6 Laser Therapy
4.7 Others
Chapter 5: Alopecia Treatment Market by Type of Alopecia (2018-2032)
5.1 Alopecia Treatment Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Androgenic Alopecia
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Alopecia Areata
5.5 Telogen Effluvium
5.6 Cicatricial Alopecia
5.7 Others
Chapter 6: Alopecia Treatment Market by End-User (2018-2032)
6.1 Alopecia Treatment Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Clinics
6.5 Home Care
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Alopecia Treatment Market Share by Manufacturer (2024)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ALLERGAN (IRELAND)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 BOSLEY (USA)
7.4 MERCK & CO. (USA)
7.5 HUGEL (SOUTH KOREA)
7.6 REVIVA LABS (USA)
7.7 ROGAINE (USA)
7.8 HAIR CLUB (USA)
7.9 STEMCELL TECHNOLOGIES (CANADA)
7.10 TUCEL (USA)
7.11 BAUSCH HEALTH (CANADA)
7.12 OTHER ACTIVE PLAYERS
Chapter 8: Global Alopecia Treatment Market By Region
8.1 Overview
8.2. North America Alopecia Treatment Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Treatment Type
8.2.4.1 Medications
8.2.4.2 Hair Transplantation
8.2.4.3 Platelet-Rich Plasma(PRP) Therapy
8.2.4.4 Laser Therapy
8.2.4.5 Others
8.2.5 Historic and Forecasted Market Size By Type of Alopecia
8.2.5.1 Androgenic Alopecia
8.2.5.2 Alopecia Areata
8.2.5.3 Telogen Effluvium
8.2.5.4 Cicatricial Alopecia
8.2.5.5 Others
8.2.6 Historic and Forecasted Market Size By End-User
8.2.6.1 Hospitals
8.2.6.2 Clinics
8.2.6.3 Home Care
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Alopecia Treatment Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Treatment Type
8.3.4.1 Medications
8.3.4.2 Hair Transplantation
8.3.4.3 Platelet-Rich Plasma(PRP) Therapy
8.3.4.4 Laser Therapy
8.3.4.5 Others
8.3.5 Historic and Forecasted Market Size By Type of Alopecia
8.3.5.1 Androgenic Alopecia
8.3.5.2 Alopecia Areata
8.3.5.3 Telogen Effluvium
8.3.5.4 Cicatricial Alopecia
8.3.5.5 Others
8.3.6 Historic and Forecasted Market Size By End-User
8.3.6.1 Hospitals
8.3.6.2 Clinics
8.3.6.3 Home Care
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Alopecia Treatment Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Treatment Type
8.4.4.1 Medications
8.4.4.2 Hair Transplantation
8.4.4.3 Platelet-Rich Plasma(PRP) Therapy
8.4.4.4 Laser Therapy
8.4.4.5 Others
8.4.5 Historic and Forecasted Market Size By Type of Alopecia
8.4.5.1 Androgenic Alopecia
8.4.5.2 Alopecia Areata
8.4.5.3 Telogen Effluvium
8.4.5.4 Cicatricial Alopecia
8.4.5.5 Others
8.4.6 Historic and Forecasted Market Size By End-User
8.4.6.1 Hospitals
8.4.6.2 Clinics
8.4.6.3 Home Care
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Alopecia Treatment Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Treatment Type
8.5.4.1 Medications
8.5.4.2 Hair Transplantation
8.5.4.3 Platelet-Rich Plasma(PRP) Therapy
8.5.4.4 Laser Therapy
8.5.4.5 Others
8.5.5 Historic and Forecasted Market Size By Type of Alopecia
8.5.5.1 Androgenic Alopecia
8.5.5.2 Alopecia Areata
8.5.5.3 Telogen Effluvium
8.5.5.4 Cicatricial Alopecia
8.5.5.5 Others
8.5.6 Historic and Forecasted Market Size By End-User
8.5.6.1 Hospitals
8.5.6.2 Clinics
8.5.6.3 Home Care
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Alopecia Treatment Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Treatment Type
8.6.4.1 Medications
8.6.4.2 Hair Transplantation
8.6.4.3 Platelet-Rich Plasma(PRP) Therapy
8.6.4.4 Laser Therapy
8.6.4.5 Others
8.6.5 Historic and Forecasted Market Size By Type of Alopecia
8.6.5.1 Androgenic Alopecia
8.6.5.2 Alopecia Areata
8.6.5.3 Telogen Effluvium
8.6.5.4 Cicatricial Alopecia
8.6.5.5 Others
8.6.6 Historic and Forecasted Market Size By End-User
8.6.6.1 Hospitals
8.6.6.2 Clinics
8.6.6.3 Home Care
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Alopecia Treatment Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Treatment Type
8.7.4.1 Medications
8.7.4.2 Hair Transplantation
8.7.4.3 Platelet-Rich Plasma(PRP) Therapy
8.7.4.4 Laser Therapy
8.7.4.5 Others
8.7.5 Historic and Forecasted Market Size By Type of Alopecia
8.7.5.1 Androgenic Alopecia
8.7.5.2 Alopecia Areata
8.7.5.3 Telogen Effluvium
8.7.5.4 Cicatricial Alopecia
8.7.5.5 Others
8.7.6 Historic and Forecasted Market Size By End-User
8.7.6.1 Hospitals
8.7.6.2 Clinics
8.7.6.3 Home Care
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Alopecia Treatment Market by Treatment Type (2018-2032)
4.1 Alopecia Treatment Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Medications
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Hair Transplantation
4.5 Platelet-Rich Plasma(PRP) Therapy
4.6 Laser Therapy
4.7 Others
Chapter 5: Alopecia Treatment Market by Type of Alopecia (2018-2032)
5.1 Alopecia Treatment Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Androgenic Alopecia
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Alopecia Areata
5.5 Telogen Effluvium
5.6 Cicatricial Alopecia
5.7 Others
Chapter 6: Alopecia Treatment Market by End-User (2018-2032)
6.1 Alopecia Treatment Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Clinics
6.5 Home Care
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Alopecia Treatment Market Share by Manufacturer (2024)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ALLERGAN (IRELAND)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 BOSLEY (USA)
7.4 MERCK & CO. (USA)
7.5 HUGEL (SOUTH KOREA)
7.6 REVIVA LABS (USA)
7.7 ROGAINE (USA)
7.8 HAIR CLUB (USA)
7.9 STEMCELL TECHNOLOGIES (CANADA)
7.10 TUCEL (USA)
7.11 BAUSCH HEALTH (CANADA)
7.12 OTHER ACTIVE PLAYERS
Chapter 8: Global Alopecia Treatment Market By Region
8.1 Overview
8.2. North America Alopecia Treatment Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Treatment Type
8.2.4.1 Medications
8.2.4.2 Hair Transplantation
8.2.4.3 Platelet-Rich Plasma(PRP) Therapy
8.2.4.4 Laser Therapy
8.2.4.5 Others
8.2.5 Historic and Forecasted Market Size By Type of Alopecia
8.2.5.1 Androgenic Alopecia
8.2.5.2 Alopecia Areata
8.2.5.3 Telogen Effluvium
8.2.5.4 Cicatricial Alopecia
8.2.5.5 Others
8.2.6 Historic and Forecasted Market Size By End-User
8.2.6.1 Hospitals
8.2.6.2 Clinics
8.2.6.3 Home Care
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Alopecia Treatment Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Treatment Type
8.3.4.1 Medications
8.3.4.2 Hair Transplantation
8.3.4.3 Platelet-Rich Plasma(PRP) Therapy
8.3.4.4 Laser Therapy
8.3.4.5 Others
8.3.5 Historic and Forecasted Market Size By Type of Alopecia
8.3.5.1 Androgenic Alopecia
8.3.5.2 Alopecia Areata
8.3.5.3 Telogen Effluvium
8.3.5.4 Cicatricial Alopecia
8.3.5.5 Others
8.3.6 Historic and Forecasted Market Size By End-User
8.3.6.1 Hospitals
8.3.6.2 Clinics
8.3.6.3 Home Care
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Alopecia Treatment Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Treatment Type
8.4.4.1 Medications
8.4.4.2 Hair Transplantation
8.4.4.3 Platelet-Rich Plasma(PRP) Therapy
8.4.4.4 Laser Therapy
8.4.4.5 Others
8.4.5 Historic and Forecasted Market Size By Type of Alopecia
8.4.5.1 Androgenic Alopecia
8.4.5.2 Alopecia Areata
8.4.5.3 Telogen Effluvium
8.4.5.4 Cicatricial Alopecia
8.4.5.5 Others
8.4.6 Historic and Forecasted Market Size By End-User
8.4.6.1 Hospitals
8.4.6.2 Clinics
8.4.6.3 Home Care
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Alopecia Treatment Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Treatment Type
8.5.4.1 Medications
8.5.4.2 Hair Transplantation
8.5.4.3 Platelet-Rich Plasma(PRP) Therapy
8.5.4.4 Laser Therapy
8.5.4.5 Others
8.5.5 Historic and Forecasted Market Size By Type of Alopecia
8.5.5.1 Androgenic Alopecia
8.5.5.2 Alopecia Areata
8.5.5.3 Telogen Effluvium
8.5.5.4 Cicatricial Alopecia
8.5.5.5 Others
8.5.6 Historic and Forecasted Market Size By End-User
8.5.6.1 Hospitals
8.5.6.2 Clinics
8.5.6.3 Home Care
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Alopecia Treatment Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Treatment Type
8.6.4.1 Medications
8.6.4.2 Hair Transplantation
8.6.4.3 Platelet-Rich Plasma(PRP) Therapy
8.6.4.4 Laser Therapy
8.6.4.5 Others
8.6.5 Historic and Forecasted Market Size By Type of Alopecia
8.6.5.1 Androgenic Alopecia
8.6.5.2 Alopecia Areata
8.6.5.3 Telogen Effluvium
8.6.5.4 Cicatricial Alopecia
8.6.5.5 Others
8.6.6 Historic and Forecasted Market Size By End-User
8.6.6.1 Hospitals
8.6.6.2 Clinics
8.6.6.3 Home Care
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Alopecia Treatment Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Treatment Type
8.7.4.1 Medications
8.7.4.2 Hair Transplantation
8.7.4.3 Platelet-Rich Plasma(PRP) Therapy
8.7.4.4 Laser Therapy
8.7.4.5 Others
8.7.5 Historic and Forecasted Market Size By Type of Alopecia
8.7.5.1 Androgenic Alopecia
8.7.5.2 Alopecia Areata
8.7.5.3 Telogen Effluvium
8.7.5.4 Cicatricial Alopecia
8.7.5.5 Others
8.7.6 Historic and Forecasted Market Size By End-User
8.7.6.1 Hospitals
8.7.6.2 Clinics
8.7.6.3 Home Care
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Alopecia Treatment Market Scope:
|
Global Alopecia Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 8.60 Billion |
|
Forecast Period 2024-32 CAGR: |
10.30% |
Market Size in 2032: |
USD 20.78 Billion |
|
Segments Covered: |
Treatment Type |
|
|
|
Type of Alopecia |
|
||
|
End-User |
Home Care |
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Frequently Asked Questions :
What would be the forecast period in the Alopecia Treatment Market research report?
The forecast period in the Alopecia Treatment Market research report is 2024-2032.
Who are the key players in the Alopecia Treatment Market?
Allergan (Ireland), Bosley (USA), Merck & Co. (USA), Hugel (South Korea), Reviva Labs (USA), Rogaine (USA), Hair Club (USA), Stemcell Technologies (Canada), Tucel (USA), Bausch Health (Canada), and Other Active Players.
What are the segments of the Alopecia Treatment Market?
The Alopecia Treatment Market is segmented into Treatment Type, Type of Alopecia, End-User and region. Treatment Type, the market is categorized into Medications, Hair Transplantation, Platelet-Rich Plasma (PRP) Therapy, Laser Therapy, Others. Type of Alopecia, the market is categorized into Androgenic Alopecia, Alopecia Areata, Telogen Effluvium, Cicatricial Alopecia, Others. End-User, the market is categorized into Hospitals, Clinics, Home Care. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
What is the Alopecia Treatment Market?
Alopecia Treatment Market consists of products and services used for treatment of hair loss conditions such as androgenic alopecia, alopecia areata and other types of hair thinning. The above treatment encompasses drugs, hair transplantation surgery, non-surgery therapies including PRP therapy, and laser therapy. The market is fueled by the rising need for a remedy to different kinds of baldness with more emphasis put on the health and beauty of hair regrowth.
How big is the Alopecia Treatment Market?
Alopecia Treatment Market Size Was Valued at USD 8.60 Billion in 2023, and is Projected to Reach USD 20.78 Billion by 2032, Growing at a CAGR of 10.30% From 2024-2032.
